Marvell Stock Hits 25-Year High as S&P Rank Climbs Higher
Marvell Technology’s stock rises to a 25-year high, lifting its S&P 500 position to No. 22. Analysts point to AI-driv...
What Moves Stock Indices Up Or Down
Stock indices move on earnings, policy changes, and macro data. This intro covers the core catalysts that drive daily swings.
23,761 articlesPrediction: This Stock Going to Plummet in H2 2026 Markets
A top tech stock faces a likely pullback in the second half of 2026 as demand shifts and costs rise. Traders should h...
This AI Stock Can’t Stop Delivering Gains for Investors
Alphabet posts stronger-than-expected Q1 2026 results driven by its vertically integrated AI stack, reinforcing its r...
Kirby Posts $6.33 2025: Fund Bets $25M on Marine Operator
A prominent fund has taken a sizable stake in Kirby Corporation, with eyes on a bold earnings target of $6.33 per sha...
Prediction: This Neocloud Stock Could Outperform in 2026
A new AI compute niche is gaining attention as investors search for growth beyond mega-cap tech. This article outline...
Three Dividend Stocks Right Never to Hold Forever Always
Looking for reliable, income-generating investments you can hold for decades? This guide picks three dividend stocks ...
Lululemon Flubbed Quarter, Founder: What Investors Need
Lululemon posted a mixed quarter: international sales led growth while the core US market softened. This analysis dig...
Prediction: Alphabet Stock Will Outpace Markets in 2026
Alphabet stock appears positioned to outpace the broader market in 2026 as AI leadership strengthens its cloud and se...
Stock Market Live July 7, 2026: S&P Drops on Tech Worries
Tech-led selling pushed the S&P 500 lower on July 7, 2026, as AI demand concerns weigh on sentiment and earnings sign...
Here's Wouldn't Touch Tilray: A Cautious Investor Guide
Tilray’s pivot to CBD and alcohol sparks questions about profitability and risk. This guide cuts through the hype, of...
Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
MakeMyTrip (MMYT) 2026 Earnings: Investor Insights
MakeMyTrip faces a pivotal year as makemytrip (mmyt) 2026 earnings reveal growth amid rising costs. This analysis bre...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status